Cite
Schirmer AU, Driver LM, Zhao MT, et al. Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. Mol Ther. 2021;30(1):485-500doi: 10.1016/j.ymthe.2021.08.029.
Schirmer, A. U., Driver, L. M., Zhao, M. T., Wells, C. I., Pickett, J. E., O'Bryne, S. N., Eduful, B. J., Yang, X., Howard, L., You, S., Devi, G. R., DiGiovanni, J., Freedland, S. J., Chi, J. T., Drewry, D. H., & Macias, E. (2022). Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. Molecular therapy : the journal of the American Society of Gene Therapy, 30(1), 485-500. https://doi.org/10.1016/j.ymthe.2021.08.029
Schirmer, Amelia U, et al. "Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer." Molecular therapy : the journal of the American Society of Gene Therapy vol. 30,1 (2022): 485-500. doi: https://doi.org/10.1016/j.ymthe.2021.08.029
Schirmer AU, Driver LM, Zhao MT, Wells CI, Pickett JE, O'Bryne SN, Eduful BJ, Yang X, Howard L, You S, Devi GR, DiGiovanni J, Freedland SJ, Chi JT, Drewry DH, Macias E. Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. Mol Ther. 2022 Jan 05;30(1):485-500. doi: 10.1016/j.ymthe.2021.08.029. Epub 2021 Aug 25. PMID: 34450249.
Copy
Download .nbib